A comprehensive, model-based review of vaccine and repeat infection trials for filariasis

CP Morris, H Evans, SE Larsen… - Clinical microbiology …, 2013 - Am Soc Microbiol
Filarial worms cause highly morbid diseases such as elephantiasis and river blindness.
Since the 1940s, researchers have conducted vaccine trials in 27 different animal models of …

Lymphatic filariasis vaccine development: neglected for how long?

VP Chavda, A Pandya, S Pulakkat… - Expert Review of …, 2021 - Taylor & Francis
Introduction Lymphatic filariasis (LF), also known as elephantiasis, has been recognized by
the world health organization and the centers for disease control and prevention as one of …

Multivalent fusion protein vaccine for lymphatic filariasis

G Dakshinamoorthy, AK Samykutty, G Munirathinam… - Vaccine, 2013 - Elsevier
Lymphatic filariasis affects approximately 3% of the whole world population. Mass drug
administration is currently the major control strategy to eradicate this infection from endemic …

The impact of gene knock-down and vaccination against salivary metalloproteases on blood feeding and egg laying by Ixodes ricinus

Y Decrem, M Mariller, K Lahaye, V Blasioli… - International journal for …, 2008 - Elsevier
Two cDNAs coding homologous putative metalloproteases (Metis 1 and Metis 2, expected
molecular weights of 55.6 and 56.0 kDa, respectively) were identified from the hard tick …

Vaccination with 73 kDa recombinant heavy chain myosin generates high level of protection against Brugia malayi challenge in jird and mastomys models

S Vedi, A Dangi, K Hajela, S Misra-Bhattacharya - Vaccine, 2008 - Elsevier
We have earlier reported identification, expression and purification of a 2.0 kb cDNA clone
coding for Brugia malayi heavy chain myosin which exhibited strong immuno-reactivity with …

A combination of two Brugia malayi filarial vaccine candidate antigens (BmALT-2 and BmVAH) enhances immune responses and protection in jirds

SB Anand, KN Kodumudi, MV Reddy… - Journal of …, 2011 - cambridge.org
In this study filarial recombinant protein or DNA vaccine constructs encoding BmALT-2 and
BmVAH as single or as cocktail antigens were evaluated. Male jirds were immunized …

Filariasis: Current status, treatment and recent advances in drug development

D Katiyar, LK Singh - Current medicinal chemistry, 2011 - ingentaconnect.com
Lymphatic filariasis, onchocerciasis and loiasis caused by human filarial nematodes are
diseases of tropical and subtropical countries causing considerable morbidity. The available …

Large extracellular loop of tetraspanin as a potential vaccine candidate for filariasis

G Dakshinamoorthy, G Munirathinam, K Stoicescu… - PLoS …, 2013 - journals.plos.org
Lymphatic filariasis affects nearly 120 million people worldwide and mass preventive
chemotherapy is currently used as a strategy to control this infection. This has substantially …

Filarial glutathione-S-transferase: a potential vaccine candidate against lymphatic filariasis

S Rathaur, M Yadav, S Gupta, V Anandharaman… - Vaccine, 2008 - Elsevier
Present report enumerates the vaccine potential of a glutathione-S-transferase purified from
Setaria cervi against lymphatic filariasis. In jirds (Meriones unguiculatus) vaccination trial, a …

Towards novel antifilarial drugs: challenges and recent developments

PK Singh, A Ajay, S Kushwaha, RP Tripathi… - Future medicinal …, 2010 - Taylor & Francis
Filariasis is caused by thread-like nematode worms, classified according to their presence in
the vertebrate host. The cutaneous group includes Onchocerca volvulus, Loa loa and …